Article Correctness Is Author's Responsibility: Copaxone 3 Times Weekly Safe, Effective for Ambulatory Patients With Relapsing MS

The article below may contain offensive and/or incorrect content.

Participants showed a significant decrease in annual relapse rate and a significant improvement in both patient-reported disability scores and information processing scores.